In squamous cell carcinoma (SCC) galectin-3 expression was positive in 11 from 24 tumor specimens (45.83%), in adenocarcinoma in 4 from 15 (26,67%), in large cell carcinoma in 2 from 4 (50%) and in non- small cell lung cancer of unspecified type in 1 from 4 (25%). Here, LGALS3 is linked to squamous cell carcinoma.